Cargando…
HIV: how to manage dyslipidaemia in HIV
BACKGROUND: Dyslipidaemia is a common metabolic condition occurring in people with HIV (PWH), whether treated or untreated with antiretroviral therapy (ART). As people live longer with HIV, ongoing lipid abnormalities may contribute to increased cardiovascular disease risk. This article aims to prov...
Autor principal: | Lee, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903877/ https://www.ncbi.nlm.nih.gov/pubmed/35310301 http://dx.doi.org/10.7573/dic.2021-8-7 |
Ejemplares similares
-
Established and Emerging Approaches for the Management of Dyslipidaemia
por: Norata, Giuseppe Danilo
Publicado: (2012) -
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021) -
Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021) -
Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia
por: Boccara, Franck, et al.
Publicado: (2017) -
The Effects of Dietary Intervention on HIV Dyslipidaemia: A Systematic Review and Meta-Analysis
por: Stradling, Clare, et al.
Publicado: (2012)